Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 3, 2009, Pages 249-253

  Fang, Yu Ming Victor ^a   MacKeen, Dhanya ^a   Egan, James F X ^a   Zelop, Carolyn M ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Gestational diabetes; Insulin glargine; Neonatal outcomes; NPH insulin; Pregestational diabetes; Pregnancy outcomes

Indexed keywords

INSULIN; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE;

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DEATH; FETUS MALFORMATION; HUMAN; HYDRAMNIOS; HYPOGLYCEMIA; MACROSOMIA; MAJOR CLINICAL STUDY; NEWBORN JAUNDICE; NEWBORN PERIOD; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETINOPATHY; RETROSPECTIVE STUDY; RISK; SIDE EFFECT; TREATMENT OUTCOME; COMPARATIVE STUDY; MALE; NEWBORN; PREGNANCY;

ADULT; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; INSULIN, NPH; MALE; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 67650499142     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050802638170     Document Type: Article

References (18)

1. Hirsch IB. Insulin analogues.NEngl J Med 2005;352:174-183.
2. Barnett AH. A review of basal insulins. Diabet Med 2003;20:873-885.
3. Poyhonen-Alho M, Ronnemma T, Saltevo J, Ekbald U, Kaaja R. Use of insulin glargine during pregnancy. Acta Obstet Gynecol 2007;86:1171-1174.
4. Price N, Bartlett C, Gillmer. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG 2007;114:453-457.
5. Gallen IW, Jaap A, Roland JM, Chirayath. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 2008;25:165-169.
6. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care 2005;28:2594-2595.
7. Torlone E, Gennarini A, Ricci NB, Bolli GB. Successful use of insulin glargine during entire pregnancy until delivery in six type 1 diabetic women. Eur J Obstet Gynecol Reprod Biol 2007;132:238-239.
8. Lapolla A, Dalfra MG, Fedele D. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? Diabetes Metab Res Rev 2005;21:241-252.
9. Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773.
10. ACOG Practice Bulletin. Gestational diabetes. Number 30, September 2001.
11. Alexander GR, Himes JH, Kaufman RB, Mor J. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-168.
12. White P. Classification of obstetric diabetes. Am J Obstet Gynecol 1978;130:228-230.
13. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time action profile of the long acting insulin analogue insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644-649.
14. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB. Pharacokinetics and pharmacodynamics of subcutaneous injection of long acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-2148.
15. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C, Trub T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005.
16. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol 2002;21:181-189. (Pubitemid 34803493)
17. Greene MF. Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clin Perinatol 1993;20:533-547.
18. Presented at the 56th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists. New Orleans, Louisiana 3-7 May 2008.